Literature DB >> 15566999

Statins for patients with type 2 diabetes.

Giuseppe Pimpinella, Renato Bertini Malgarini, Nello Martini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15566999     DOI： 10.1016/S0140-6736(04)17462-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Statins and CVD prevention in the diabetic population: implications of the CARDS trial.

Authors:  Omar Murad; John Palmer; James Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

2.  Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).

Authors:  M Raikou; A McGuire; H M Colhoun; D J Betteridge; P N Durrington; G A Hitman; H A W Neil; S J Livingstone; V Charlton-Menys; J H Fuller
Journal:  Diabetologia       Date:  2007-01-31       Impact factor: 10.122

3.  Atorvastatin up-regulates TRIB3 independent of ATF4-CHOP pathway in atherosclerotic patients.

Authors:  Shao-Jie Bi; Chun-Yan Wang; Juan Zhang; Zhao-Peng Lv; Yi-Xin Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.